Gut–liver axis: an immune link between celiac disease and primary biliary cirrhosis

References

• Mehal WZ. The gut–liver axis: a busy two-way street. Hepatology 55(6), 1647–1649 (2012).
   PubMed Web of Science ®Google Scholar
• Stevens FM, McLoughlin RM. Is coeliac disease a potentially treatable cause of liver failure? Eur. J. Gastroenterol. Hepatol. 17(10), 1015–1017 (2005).
   PubMed Web of Science ®Google Scholar
• Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat. Rev. Immunol. 6(3), 244–251 (2006).
   PubMed Web of Science ®Google Scholar
• Volta U. Pathogenesis and clinical significance of liver injury in celiac disease. Clin. Rev. Allergy Immunol. 36(1), 62–70 (2009).
   PubMed Web of Science ®Google Scholar
• Hagander B, Berg NO, Brandt L, Nordén A, Sjölund K, Stenstam M. Hepatic injury in adult coeliac disease. Lancet 2(8032), 270–272 (1977).
   PubMed Web of Science ®Google Scholar
• Lindberg T, Berg NO, Borulf S, Jakobsson I. Liver damage in coeliac disease or other food intolerance in childhood. Lancet 1(8060), 390–391 (1978).
   PubMed Web of Science ®Google Scholar
• Fausa O, Elgjo K, Schrumpf E. Hepatic lesions in adult coeliac disease. Scand. J. Gastroenterol. 25(7), 656–662 (1990).
   PubMed Web of Science ®Google Scholar
• Volta U, De Franceschi L, Molinaro N et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig. Dis. Sci. 43(10), 2190–2195 (1998).
   PubMed Web of Science ®Google Scholar
• Volta U, Rodrigo L, Granito A et al. Celiac disease in autoimmune cholestatic liver disorders. Am. J. Gastroenterol. 97(10), 2609–2613 (2002).
   PubMed Web of Science ®Google Scholar
• Villalta D, Girolami D, Bidoli E et al. High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies. J. Clin. Lab. Anal. 19(1), 6–10 (2005).
   PubMed Web of Science ®Google Scholar
• Duggan JM, Duggan AE. Systematic review: the liver in coeliac disease. Aliment. Pharmacol. Ther. 21(5), 515–518 (2005).
   PubMed Web of Science ®Google Scholar
• Volta U, Villanacci V. Celiac disease: diagnostic criteria in progress. Cell. Mol. Immunol. 8(2), 96–102 (2011).
   PubMed Web of Science ®Google Scholar
• Guandalini S, Ventura A, Ansaldi N et al. Diagnosis of coeliac disease: time for a change? Arch. Dis. Child. 64(9), 1320–1324 (1989).
   PubMed Web of Science ®Google Scholar
• Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann. Intern. Med. 142(4), 289–298 (2005).
   PubMed Web of Science ®Google Scholar
• Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3(7), 797–801 (1997).
   PubMed Web of Science ®Google Scholar
• Mäki M, Mustalahti K, Kokkonen J et al. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348(25), 2517–2524 (2003).
   PubMed Web of Science ®Google Scholar
• Mustalahti K, Catassi C, Reunanen A et al.; Coeliac EU Cluster, Project Epidemiology. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann. Med. 42(8), 587–595 (2010).
   PubMed Web of Science ®Google Scholar
• Karell K, Louka AS, Moodie SJ et al. HLA types in celiac disease patients not carrying the DQA1*05–DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 64(4), 469–477 (2003).
   PubMed Web of Science ®Google Scholar
• Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119(1), 234–242 (2000).
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Corazza GR. Coeliac disease. Lancet 373(9673), 1480–1493 (2009).
   PubMed Web of Science ®Google Scholar
• Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am. J. Med. 123(8), 691–693 (2010).
   PubMed Web of Science ®Google Scholar
• Basso D, Guariso G, Fogar P et al. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin. Chem. 55(1), 150–157 (2009).
   PubMed Web of Science ®Google Scholar
• Mozo L, Gómez J, Escanlar E, Bousoño C, Gutiérrez C. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. J. Pediatr. Gastroenterol. Nutr. 55(1), 50–55 (2012).
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Korponay-Szabó IR et al.; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 54(1), 136–160 (2012).
   PubMed Web of Science ®Google Scholar
• Martucci S, Corazza GR. Spreading and focusing of gluten epitopes in celiac disease. Gastroenterology 122(7), 2072–2075 (2002).
   PubMed Web of Science ®Google Scholar
• Volta U, Ballardini G, Molinaro N, De Franceschi L, Groff P, Bianchi FB. Specific reactivity of fluorescein isothiocyanate-conjugated separated IgG and IgA from celiac disease sera on human tissues. Int. J. Clin. Lab. Res. 25(2), 110–115 (1995).
   PubMedGoogle Scholar
• Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet 377(9777), 1600–1609 (2011).
   PubMed Web of Science ®Google Scholar
• Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin. Liver Dis. 12(2), 261–276 (2008).
   PubMed Web of Science ®Google Scholar
• Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance. Dig. Dis. 10(2), 85–101 (1992).
   PubMed Web of Science ®Google Scholar
• Fussey SP, Guest JR, James OF, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc. Natl Acad. Sci. USA 85(22), 8654–8658 (1988).
   PubMed Web of Science ®Google Scholar
• Muratori P, Muratori L, Gershwin ME et al. ‘True’ antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin. Exp. Immunol. 135(1), 154–158 (2004).
   PubMed Web of Science ®Google Scholar
• Oertelt S, Rieger R, Selmi C et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45(3), 659–665 (2007).
   PubMed Web of Science ®Google Scholar
• Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin. Liver Dis. 25(3), 298–310 (2005).
   PubMed Web of Science ®Google Scholar
• Nakamura M, Kondo H, Mori T et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45(1), 118–127 (2007).
   PubMed Web of Science ®Google Scholar
• Kim WR, Lindor KD, Locke GR 3rd et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119(6), 1631–1636 (2000).
   PubMed Web of Science ®Google Scholar
• Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 127(2), 470–475 (2004).
   PubMed Web of Science ®Google Scholar
• Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53(6), 865–870 (2004).
   PubMed Web of Science ®Google Scholar
• Leslie WD, Bernstein CN, Leboff MS; American Gastroenterological Association Clinical Practice Commitee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125(3), 941–966 (2003).
   PubMed Web of Science ®Google Scholar
• Allocca M, Crosignani A, Gritti A et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 55(12), 1795–1800 (2006).
   PubMed Web of Science ®Google Scholar
• Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 50(1), 291–308 (2009).
   PubMed Web of Science ®Google Scholar
• Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31(4), 1005–1013 (2000).
   PubMed Web of Science ®Google Scholar
• Scheuer P. Primary biliary cirrhosis. Proc. R. Soc. Med. 60(12), 1257–1260 (1967).
   PubMedGoogle Scholar
• Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch. A. Pathol. Anat. Histol. 379(2), 103–112 (1978).
   PubMed Web of Science ®Google Scholar
• Padgett KA, Selmi C, Kenny TP et al. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J. Autoimmun. 24(3), 209–219 (2005).
   PubMed Web of Science ®Google Scholar
• Rigamonti C, Shand LM, Feudjo M et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55(3), 388–394 (2006).
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL. Clinical practice guidelines: management of cholestatic liver diseases. J. Hepatol. 51(2), 237–267 (2009).
   PubMed Web of Science ®Google Scholar
• Lindor KD. Farnesoid X receptor agonists for primary biliary cirrhosis. Curr. Opin. Gastroenterol. 27(3), 285–288 (2011).
   PubMed Web of Science ®Google Scholar
• Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J. Clin. Gastroenterol. 25(1), 328–329 (1997).
   PubMed Web of Science ®Google Scholar
• Bardella MT, Quatrini M, Zuin M et al. Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am. J. Gastroenterol. 92(9), 1524–1526 (1997).
   PubMed Web of Science ®Google Scholar
• Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42(1), 120–122 (1998).
   PubMed Web of Science ®Google Scholar
• Niveloni S, Dezi R, Pedreira S et al. Gluten sensitivity in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 93(3), 404–408 (1998).
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Thulstrup AM, Blomqvist P, Nørgaard B, Fonager K, Ekbom A. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 44(5), 736–738 (1999).
   PubMed Web of Science ®Google Scholar
• Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can. J. Gastroenterol. 14(8), 672–675 (2000).
   PubMed Web of Science ®Google Scholar
• Floreani A, Betterle C, Baragiotta A et al. Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig. Liver Dis. 34(4), 258–261 (2002).
   PubMedGoogle Scholar
• Chatzicostas C, Roussomoustakaki M, Drygiannakis D et al. Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete. BMC Gastroenterol. 2, 5(2002).
   Google Scholar
• Habior A, Lewartowska A, Orlowska J et al. Association of coeliac disease with primary biliary cirrhosis in Poland. Eur. J. Gastroenterol. Hepatol. 15(2), 159–164 (2003).
   PubMed Web of Science ®Google Scholar
• Oberhüber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol. 11(10), 1185–1194 (1999).
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Villalta D, Tonutti E et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig. Dis. Sci. 48(12), 2360–2365 (2003).
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Tampoia M, Villalta D et al. Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis. J. Clin. Lab. Anal. 20(5), 184–189 (2006).
   PubMed Web of Science ®Google Scholar
• Zanoni G, Navone R, Lunardi C et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 3(9), e358 (2006).
   PubMed Web of Science ®Google Scholar
• Stene LC, Honeyman MC, Hoffenberg EJ et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 101(10), 2333–2340 (2006).
   PubMed Web of Science ®Google Scholar
• Selmi C, Balkwill DL, Invernizzi P et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38(5), 1250–1257 (2003).
   PubMed Web of Science ®Google Scholar
• Selmi C, Gershwin ME. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr. Opin. Rheumatol. 16(4), 406–410 (2004).
   PubMed Web of Science ®Google Scholar
• Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin. Rev. Allergy Immunol. 36(1), 30–39 (2009).
   PubMed Web of Science ®Google Scholar
• Berg CP, Kannan TR, Klein R et al. Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int. 29(6), 797–809 (2009).
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Arena V, Giancotti F, Vecchio FM, Abenavoli S. Celiac disease, primary biliary cirrhosis and Helicobacter pylori infection: one link for three diseases. Int. J. Immunopathol. Pharmacol. 23(4), 1261–1265 (2010).
   PubMed Web of Science ®Google Scholar
• Sanz Y, De Pama G, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int. Rev. Immunol. 30(4), 207–218 (2011).
   PubMed Web of Science ®Google Scholar
• Corazza G, Valentini RA, Frisoni M et al. Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients. Gastroenterology 103(5), 1517–1522 (1992).
   PubMed Web of Science ®Google Scholar
• Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am. J. Gastroenterol. 98(2), 377–381 (2003).
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Liu X, Xu C et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360(24), 2544–2555 (2009).
   PubMed Web of Science ®Google Scholar
• Liu X, Invernizzi P, Lu Y et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet. 42(8), 658–660 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Y, Helms C, Liao W et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4(3), e1000041 (2008).
   PubMed Web of Science ®Google Scholar
• Plaza-Izurieta L, Castellanos-Rubio A, Irastorza I, Fernández-Jimenez N, Gutierrez G, Bilbao JR; CEGEC. Revisiting genome wide association studies (GWAS) in coeliac disease: replication study in Spanish population and expression analysis of candidate genes. J. Med. Genet. 48(7), 493–496 (2011).
   PubMed Web of Science ®Google Scholar
• Zhernakova A, Stahl EA, Trynka G et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 7(2), e1002004 (2011).
   PubMed Web of Science ®Google Scholar
• Trynka G, Wijmenga C, van Heel DA. A genetic perspective on coeliac disease. Trends Mol. Med. 16(11), 537–550 (2010).
   PubMed Web of Science ®Google Scholar
• Miyake Y, Yamamoto K. Role of gut microbiota in liver diseases. Hepatol. Res. doi:10.1111/j.1872-034X.2012.01088 (2012) (Epub ahead of print).
   Google Scholar
• Charatcharoenwitthaya P, Pimentel S, Talwalkar JA et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl. 13(9), 1236–1245 (2007).
   PubMed Web of Science ®Google Scholar